Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Advancing Patient Care with Antibody-Drug Conjugate Therapies in HER2-Negative and HER2-Low Metastatic Breast Cancer : Episode 14
Opinion
Video
Discussing ADC Risks, Benefits, and Regimens With Patients
Panelists discuss how health care professionals use clear, tailored communication to explain antibody-drug conjugate (ADC) risks, benefits, and regimens. They provide education, address concerns, and ensure adherence through counseling and shared decision-making.
Video content above has been prompted by the following:
- At your institution, how do you effectively communicate with patients about ADC therapies (eg, risks, benefits, treatment regimens)?
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Videos
Related Content
